Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A solid budget helps young professionals manage irregular income and set aside funds for future goals.
19,978 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
MP Materials is at the center of America’s push to secure essential minerals. This guide breaks down whether now is t...
A sudden 17% intraday surge in Brady Corporation has investors buzzing. This piece breaks down how AI-linked demand f...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Hyliion Holdings stock charged higher today as new analyst coverage and operational milestones sparked optimism. This...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
When big builders cut prices to move inventory, investors win—if they know how to structure deals. This guide breaks ...
As 2026 politics intensify, Trump claims the U.S. economy is the strongest in history. This article weighs the data a...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
Powell Industries may fly under the radar, but patient investors can uncover a potential opportunity. This guide brea...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...